iBody Inc.
PrivateLast Round
Strategic
Jan 5, 2023
Est. Valuation
$8.08M
Total Funding Raised
$3.21M
Company Overview
iBody Inc. operates in Healthcare & Life Sciences and is based in Nagoya. Its latest recorded funding round was a Strategic round in January 2023.
iBody Inc. is a biotechnology company that provides a monoclonal antibody discovery platform and contract research services for pharmaceutical and diagnostic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iBody Inc. Comparables
Compare iBody Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Epsilon Molecular Engineering, Inc. | 85% | |
| 株式会社イーベック | 80% | |
| MabGenesis株式会社 | 78% |
For institutional investors. Book with your work email.
iBody Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 5, 2023 | ||||
| VC Round | Aug 3, 2020 | ||||
| Seed | May 16, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
iBody Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OKB Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2026
Monthly visitors increased 80% MoM.
- Mar 3, 2026
Monthly visitors increased 37% MoM, reaching 2.1K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 29, 2026
iBody Inc partners with PATH, with support from the GHIT Fund, to develop a diagnostic that enables early Nipah virus and Hendra virus outbreak detection in rural and low-resource settings on Oct 29th '26.
For institutional investors. Book with your work email.
iBody Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about iBody Inc.'s valuation, stock price, and market status.
Is iBody Inc. a public or private company?
iBody Inc. is a private company.
What is the current stock price of iBody Inc.?
iBody Inc. is a private company, so its shares have no public market price. Caplight tracks iBody Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is iBody Inc. worth (valuation)?
iBody Inc.'s valuation is estimated at $8.1M based on funding round data.
Can I buy iBody Inc. stock?
iBody Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was iBody Inc.'s last funding round?
iBody Inc.'s most recent funding round was Strategic on January 5, 2023.
Who are the main investors in iBody Inc.?
Key investors in iBody Inc. include OKB Capital.
Will iBody Inc. IPO soon?
No public IPO plans have been announced for iBody Inc..
How can I track iBody Inc. secondary market activity?
Caplight tracks bids, offers, and trades in iBody Inc.'s shares on secondary markets.